6533b7cefe1ef96bd12579e3

RESEARCH PRODUCT

Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients

Juan CarrizoJaume PuigFerran SerraltaManuel AlósAngels LozanoGerardo AguilarAna JuradoRafael FerriolsF. Javier BeldaCarlos EzquerDavid NavarroJosé A. Carbonell

subject

0301 basic medicineContinuous renal replacement therapymedicine.medical_specialtyLetterCritical Illness030106 microbiologyHemodiafiltrationCritical Care and Intensive Care MedicineEchinocandinsLipopeptides03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCaspofunginHumansMedicineIntensive care medicinebusiness.industryCritically illlcsh:Medical emergencies. Critical care. Intensive care. First aid030208 emergency & critical care medicinelcsh:RC86-88.9Invasive candidiasisContinuous venovenous hemodiafiltrationAcute Kidney Injurymedicine.diseaseInvasive candidiasisRenal Replacement TherapychemistryAdsorptionCaspofunginbusiness
yearjournalcountryeditionlanguage
2017-01-01Critical Care
https://doi.org/10.1186/s13054-016-1594-9